Response,Reported prevalence (confirmed cases/population),Extrapolated prevalence (from sample-based testing)
New York City (PCR testing),1.9%,15.4%
New York State (antibody testing),1.5%,14.9%
"Gangelt, Germany (antibody testing)",0.4%,14%
Geneva (antibody testing),1%,5.5%
Los Angeles (antibody testing)**,0.1%,5.6%
Santa Clara (antibody testing)**,0.05%,4.2%
